SYS6045

· CSPC Megalith Biopharmaceutical Co.,Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SYS6045, covering 2025-08-14 to 2025-08-14. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of SYS6045 in Patients With HER2-Positive, Expressing, or Mutated Advanced Malignant Solid Tumors [Phase 1, Phase 2]

See pricing